The ESMO Symposium on Signalling Pathways 2015 – Targeting the MAPK pathway: from RAS to MEK is organised by the leading professionals in the field
This is now the third edition and has become the premium event for clinicians in signalling pathways in cancer.
The Scientific Committee has planned a comprehensive and exciting educational programme that will cover preclinical data and genetics relevant for the understanding of the functional mechanisms in the RAS/ERK/MEK pathway, regulation of MAPK signalling, the rationale and strategies to inhibiting the pathway, biomarkers, mechanisms of resistance, as well as how to overcome it, and some important interactions with other pathways.
Fast Facts: ESMO Symposium on Signalling Pathways 2015
- 6 Educational Sessions
- No parallel sessions
- Interactive Q&A time after each educational session
- An internationally renowned faculty
- Excellent networking event for Industry
How can I participate in the next ESMO Symposium on Signalling Pathways 2015?
At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our conference.
Contact the ESMO Events Sponsorship Team for more details. We look forward to hearing from you!
Italian agency (AIFA applications)
The appointed agency to collect on ESMO behalf all applications from the Pharmaceutical Companies and file them with the AIFA (Italian Drug Agency) is:
Mrs. Silvia Rabotti
Via G. Ripamonti, 129
20141 Milan, Italy